Aller au contenu principal
Profil bibliographique

Enough Mbatsane

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
16Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

HIV/AIDS Research and InterventionsReproductive tract infections researchReproductive Health and ContraceptionHIV Research and TreatmentGlobal Maternal and Child Health

Les publications récentes

Accès ouvert 2024 article OpenAlex

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial

George Justus Hofmeyr, Mandisa Singata‐Madliki, Joanne R Batting, Petrus Schonken Steyn et autres

BACKGROUND: Contraceptive use has complex effects on sexual behaviour and mood, including those related to reduced concerns about unintended pregnancy, direct hormonal effects and effects on endogenous sex hormones. We set out to obtain robust evidence on the relative effects of three …

Botswana, Afrique du Sud, ch, us, Kenya (code pays fourni par la source)

2 citations PLoS ONE
Accès ouvert 2023 article OpenAlex

Prospective acceptability of a multipurpose technology (MPT) implant in preclinical development to prevent HIV and unplanned pregnancy: Qualitative insights from women end users and health care providers in South Africa and Zimbabwe

Sikhanyisiwe Nkomo, Wanzirai Makoni, Mary Kate Shapley‐Quinn, Ellen H. Luecke et autres

BACKGROUND: Given the high rates of both HIV and unintended pregnancies in sub-Saharan Africa, the SCHIELD program aims to develop a multipurpose technology implant for HIV and pregnancy prevention. An end-user evaluation was undertaken with young women and health care providers to …

Zimbabwe, us, Afrique du Sud (code pays fourni par la source)

10 citations PLoS ONE
Accès ouvert 2022 article OpenAlex

Exploring a community’s understanding of HIV vaccine‑induced seropositivity in a South African research setting

Mookho Malahleha, Athmanundh Dilraj, J Jean, NS Morar et autres

BACKGROUND: The high HIV prevalence and incidence in South Africa makes it suitable for recruitment of participants for large-scale HIV preventive vaccine trials. However, fear of vaccine-induced seropositivity (VISP) may be a barrier for community acceptability of the trial, for volunteers to …

Afrique du Sud, us (code pays fourni par la source)

4 citations South African Medical Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.